Linear regression prediction model for an outcome of Alzheimer's Disease in Down Syndrome including BPSD‐DSII sections and Alzheimer's Disease fluid biomarkers

Abstract

Background: By age 40, virtually all individuals with Down Syndrome (DS) will have developed the pathological symptoms of Alzheimer's Disease (AD) (McCarron, McCallion et al. 2017), making it the genetic leading cause of AD worldwide.